Islam mohammad Shehata

Dr. Islam mohammad Shehata

Ain Shams University, Cairo, Al Qāhirah, Egypt
orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2023 in Clinics and Practice
Verified
Journal Article
Open access
PDF file
Manar Ahmed KamalManar Ahmed Kamal
Manar Ahmed Kamal
ZIZainab Ismail
Zainab Ismail
Islam mohammad ShehataIslam mohammad Shehata
Islam mohammad Shehata
SDSoumia Djirar
Soumia Djirar
NTNorris Claiborne Talbot
Norris Claiborne Talbot
Alan David KayeAlan David Kaye
Alan David Kaye
Telemedicine, telehealth, and E-health all offer significant benefits for pain management and healthcare services by fostering the physician–patient relationship in otherwise challenging circumstances. A critical component of these artificial-intelligence-based health systems is the “agent-based system”, which is rapidly evolving as a means of resolving complicated or straightforward problems. Multi-Agent Systems (MAS) are well-established modeling and problem-solving modalities that model and solve real-world problems. MAS’s core concept is to foster communication and cooperation among agents, which are broadly considered intelligent autonomous factors, to address diverse challenges. MAS are used in various telecommunications applications, including the internet, robotics, healthcare, and medicine. Furthermore, MAS and information technology are utilized to enhance patient-centered palliative care. While telemedicine, E-health, and MAS all play critical roles in managing chronic pain, the published research on their use in treating chronic pain is currently limited. This paper discusses why telemedicine, E-health, and MAS are the most critical novel technologies for providing healthcare and managing chronic pain. This review also provides context for identifying the advantages and disadvantages of each application’s features, which may serve as a useful tool for researchers.

22 March 2022 in Neurology International
Verified
Journal Article
Open access
PDF file
Islam mohammad ShehataIslam mohammad Shehata
Islam mohammad Shehata
WMWaniyah Masood
Waniyah Masood
NNNouran Nemr
Nouran Nemr
AAAlexandra Anderson
Alexandra Anderson
KBKB Bhusal
KB Bhusal
Alan David KayeAlan David Kaye
Alan David Kaye
Depression is a leading cause of disability globally, with a prevalence of 3.8% among the whole population, 5% of the adult population, and 5.7% of the elderly population over 60 years of age. There is evidence that depression is linked to certain neurodegenerative diseases, one being Alzheimer’s disease (AD). The efficacy of conventional antidepressants to treat depression in AD is conflicting, especially regarding selective serotonin reuptake inhibitors (SSRIs). A recent systemic review and meta-analysis of 25 randomized controlled trials including fourteen antidepressant medications showed no high efficacy in treating AD patients’ symptoms. However, ketamine, a nonselective N-methyl-D-aspartate (NMDA) receptor antagonist, can mediate a wide range of pharmacological effects, including neuroprotection, anti-inflammatory and anticancer properties, multimodal analgesia, and treatment of depression, suicidal attempts, and status epilepticus. Esketamine, which is ketamine formulated as a nasal spray, was approved by the Federal Drug Administration (FDA) in March 2019 as an adjuvant drug to treat treatment-resistant depression. NMDA receptor antagonists treat AD through offsetting AD-related pathological stimulation of subtypes of glutamate receptors in the central nervous system. Recent clinical findings suggest that ketamine may provide neuroprotection and reduce neuropsychiatric symptoms associated with AD. In the present investigation, we evaluate the potential role of ketamine and its postulated mechanism in AD management.

12 January 2024 in Current Pain and Headache Reports
Verified
Journal Article
Open access
PDF file
AEAhmed Saad Elsaeidy
Ahmed Saad Elsaeidy
AAAya Hisham Moussa Ahmad
Aya Hisham Moussa Ahmad
NKNeveen A. Kohaf
Neveen A. Kohaf
AAAya Aboutaleb
Aya Aboutaleb
DKDanisha Kumar
Danisha Kumar
Islam mohammad ShehataIslam mohammad Shehata
Islam mohammad Shehata
Purpose of Review: The combination of ketamine with propofol and dexmedetomidine has gained popularity for sedation and general anesthesia in different populations. In our meta-nalysis, we helped the anesthesiologists to know the efficiency and the efficacy of both combinations in adult and pediatric patients. Methods: We searched PubMed, CENTRAL, Web of Science, and Scopus from inception to August 1, 2023. Our outcome parameters for efficacy were recovery time, pain score, and physician satisfaction while for safety were the related cardiorespiratory, neurological, and gastrointestinal adverse events. Recent Findings: Twenty-two trials were included with a total of 1429 patients. We found a significantly longer recovery time in the ketadex group of 7.59 min (95% CI, 4.92, 10.26; I2 = 94%) and a significantly less pain score of − 0.72 (95% CI, − 1.10, − 0.34; I2 = 0%). Adults had a significantly better physician satisfaction score with the ketofol group, odds ratio of 0.29 (95% CI, 0.12, 0.71; I2 = 0%). Recovery agitations were higher in the ketofol group with an odds ratio of 0.48 (95% CI, 0.24, 0.98; I2 = 36%). Furthermore, we found a significant difference between the combinations with a higher incidence in the ketadex group with pooled odds ratio of 1.75 (95% CI, 1.06, 2.88; I2 = 15%). Summary: Ketadex was associated with lower pain scores, hypoxic events and airway obstruction, and emergence agitation. At the same time, ketofol had much more clinician satisfaction which might be attributed to the shorter recovery time and lower incidence of nausea and vomiting. Therefore, we suppose that ketadex is the better combination in periprocedural sedation for both adult and pediatric patients who are not at greater risk for postoperative nausea and vomiting.

10 January 2024 in Heliyon
Verified
Journal Article
Open access
Islam mohammad ShehataIslam mohammad Shehata
Islam mohammad Shehata
NKNeveen A. Kohaf
Neveen A. Kohaf
MEMohamed W. ElSayed
Mohamed W. ElSayed
KLKaveh Latifi
Kaveh Latifi
AAAya Moustafa Aboutaleb
Aya Moustafa Aboutaleb
Alan David KayeAlan David Kaye
Alan David Kaye
Of Review: This evidence-based systematic review evaluated the safety of ketamine as regard the potential to provoke epilepsy to help better guide anesthesiologists in their practice. Ketamine, originally developed as a dissociative anesthetic, has gained attention for its potential therapeutic applications in various medical conditions, including epilepsy. Ketamine is generally well-tolerated and widely used in anesthesia, however, conflicting data are confusing the anesthesiologists regarding the potential risk of seizures associated with its use. The literature that claimed the proepileeptic property are inconsistent and the mechanism of action is unclear. Moreover, the case reports had been in same certain contexts, such as procedural sedation where ketamine was used as a single agent. On the other hand, the retrospective data analysis confirmed the positive role ketamine plays as antiepileptic agent. Many studies have shown promising results for the use of ketamine as antiepileptic agent. In case of epileptic patients, there is no contraindication for using ketamine, however, combining with benzodiazepine or propofol may enhance the safety.

1 July 2022 in Saudi Journal of Anaesthesia
Verified
Journal Article
Open access
PDF file
SDSherein Diab
Sherein Diab
JKJaeyeon Kweon
Jaeyeon Kweon
OFOssama Farrag
Ossama Farrag
Islam mohammad ShehataIslam mohammad Shehata
Islam mohammad Shehata
Bariatric surgeries are effective long-term management for morbid obesity with its adverse sequelae. Anesthesia of bariatric surgeries poses unique challenges for the anesthesiologist in every step starting with vascular access till tracheal extubation. The usage of ultrasound in anesthesia is becoming more prevalent with a variety of benefits, especially in the obese population. Ultrasound is successfully used for obtaining vascular access, with more than 15 million catheters placed in the United States alone. Ultrasound can also be used to predict difficult intubation, as it can confirm the tracheal intubation and assess the gastric content to prevent pulmonary aspiration. Ultrasound is also used in the management of mechanically ventilated patients to monitor lung aeration and to identify respiratory complications during positive pressure ventilation. Moreover, intraoperative echocardiography helps to discover the pulmonary embolism and guides the fluid therapy. Finally, ultrasound can be used to perform neuraxial and fascial plane block with a less overall time of the procedures and minimal complications. The wide use of ultrasound in bariatric anesthesia reflects the learning curve of the anesthesiologists and their mounting efforts to provide safe anesthesia utilizing the updated technology. In this review, we highlight the role of ultrasonography in anesthesia of bariatric surgery and discuss the recent guidelines.

24 February 2021 in Anesthesiology and Pain Medicine
Verified
Journal Article
Open access
PDF file
Islam mohammad ShehataIslam mohammad Shehata
Islam mohammad Shehata
AEAmir Elhassan
Amir Elhassan
DMDavid Alejandro Munoz
David Alejandro Munoz
BOBryan Okereke
Bryan Okereke
Elyse M. CornettElyse M. Cornett
Elyse M. Cornett
OVOmar Viswanath
Omar Viswanath
: Patient safety advocacy involves avoiding, preventing, and amelioration of adverse outcomes or injuries caused by the process of healthcare rather than a patient's underlying medical illness. Intraoperative hypotension (IOH), a common morbid event, reduces perfusion to critical organs and tissues and has a wide incidence, depending on how it is defined. IOH has adverse intraoperative and postoperative consequences, which make its prevention important to improve patient outcomes. Certain populations have even greater consequences related to IOH, and clinicians must understand these risks. In this narrative review, we examine the risk of intraoperative hypotension in the oncological patient population.